logo

For the Inventor, By the Inventor

Berlin, Germany

Epiontis Gmbh

Calculating rank
USPTO Granted Patents = 13



Forward Citations = 11

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Sven Olek (13 out of 28 patents)

silverMedal Udo Baron (2 out of 5 patents)

bronzeMedal Ulrich Hoffmüller (1 out of 2 patents)

4.  Jochen Huehn (1 out of 1 patent)

5.  Stefan Floess (1 out of 1 patent)

6.  Alf Hamann (1 out of 1 patent)

7.  Ulrich Hoffmueller (1 out of 1 patent)

8.  Ivana Türbachova (1 out of 3 patents)

9.  Paul Gardina (1 out of 1 patent)

10.  Tim Schwachula (0 patent)

11.  Jochen Hühn (0 patent)

12.  Stefan Flöss (0 patent)


13 patents:

1. 10894984 - Method for identifying the quantitative cellular composition in a biological sample (2021-01-19),
2. 10876163 - Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene (2020-12-29),
3. 10781492 - Epigenetic method for the identification of subpopulations of CD8+ T lymphocytes, in particular CD8 alpha and beta T lymphocytes (2020-09-22),
4. 10590475 - Detection of immune cells, in particular T cells through DNA-methylation analysis of the genes CCR6 and BLR1 (2020-03-17),
5. 10294527 - Epigenetic marker for the identification of natural killer cells (2019-05-21),
6. 10273545 - Epigenetic method for the identification of subpopulations of CD8+ T lymphocytes, in particular CD8 alpha and beta T lymphocytes (2019-04-30),
7. 10208346 - Method for identifying the quantitative cellular composition in a biological sample (2019-02-19),
8. 9926599 - Epigenetic marker for the identification of CD3CD4 positive T lymphocytes (2018-03-27),
9. 9840736 - Epigenetic marker for the identification of T lymphocytes (2017-12-12),
10. 9783846 - [object Object] (2017-10-10),
11. 9556484 - Epigenetic marker for the identification of IL17 positive T cells in complex samples (2017-01-31),
12. 9096900 - Epigenetic marker for the identification of natural killer cells (2015-08-04),
13. 8298762 - Specific DNAS for Epigenetic Characterisation of cells and tissues (2012-10-30),
Company Overview
Epiontis GmbH, based in Berlin, specializes in the development of innovative diagnostic solutions that leverage advanced molecular biology techniques. The company focuses on enhancing precision medicine through its expertise in epigenetics and biomarker discovery, aiming to improve patient outcomes in various therapeutic areas. With a commitment to research and development, Epiontis is positioned at the forefront of personalized healthcare, contributing to the evolution of diagnostics and treatment strategies in the medical field.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

Epiontis Gmbh USPTO Patent Assignee Logo
13 Patents

#73 in D-1000 Berlin

#3,087 in Germany

#45,137 in the World

Berlin, DE
Berlin, Germany

Epiontis Gmbh

Forward Citations = 11

9 inventors:

goldMedal Sven Olek (13 out of 28 patents)

silverMedal Udo Baron (2 out of 5 patents)

bronzeMedal Ulrich Hoffmüller (1 out of 2 patents)

4.  Jochen Huehn (1 out of 1 patent)

5.  Stefan Floess (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epiontis Gmbh. Retrieved from https://idiyas.com/company/epiontis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…